Home> Products> tp mate 50 tablets

{ "products": [ { "_id": "666c09b805b00e1ad41ca790", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TP MATE 50 ", "description": "TP MATE 50 \nTopiramate (50mg)\nIntroduction:\n\nTP MATE 50 contains Topiramate, a versatile anticonvulsant and migraine prophylactic medication. With a dosage strength of 50mg, TP MATE 50 is designed to manage seizures in epilepsy and prevent migraines, significantly enhancing the quality of life for patients.\nKey Features and Benefits:\n\nAnticonvulsant Action:\n\nTP MATE 50 is highly effective in treating various types of seizures, including partial-onset seizures, generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome. It stabilizes neuronal activity by enhancing GABAergic transmission, blocking sodium channels, and inhibiting glutamate activity.\nMigraine Prophylaxis:\n\nTopiramate is widely used for preventing migraines. By modulating neurotransmitter activity, TP MATE 50 reduces the frequency and severity of migraine attacks, helping patients manage their condition and improve their daily functioning.\nWeight Management:\n\nAn added benefit of TP MATE 50 is its potential to assist with weight loss. Unlike many anticonvulsants, Topiramate may lead to weight reduction, which can be beneficial for patients concerned about weight gain associated with other medications.\nMood Stabilization:\n\nTopiramate has mood-stabilizing properties, making it useful for patients with coexisting mood disorders such as bipolar disorder. It helps in stabilizing mood swings and reducing symptoms of anxiety and depression.\nWell-Tolerated and Safe:\n\nTP MATE 50 is generally well-tolerated with a favorable safety profile, making it a reliable option for long-term management of epilepsy and migraines.\nDosage and Administration:\n\nInitial Dosage for Epilepsy:\n\nThe initial dose of TP MATE 50 for adults with epilepsy typically starts at a low dose, gradually increasing to reduce the risk of side effects. A common starting dose is 25-50mg per day, increasing weekly by 25-50mg until the effective dose is reached. The usual maintenance dose ranges from 200-400mg per day, divided into two doses.\nInitial Dosage for Migraine Prophylaxis:\n\nFor migraine prevention, the initial dose is 25mg taken once daily, usually at night. The dose may be increased weekly by 25mg, up to a recommended dose of 50-100mg per day, divided into two doses.\nAdministration Instructions:\n\nTP MATE 50 tablets should be taken orally with or without food. It is important to maintain consistent dosing schedules to ensure stable therapeutic levels.\nContinued Monitoring:\n\nRegular monitoring of seizure frequency, migraine attacks, and potential side effects is essential during TP MATE 50 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/tp-mate-50-133634", "price": 99.0, "discountamount": 29.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "life", "food", "50mg", "25mg", "risk", "EMAIL", "night", "option", "adults", "anxiety", "quality", "symptoms", "severity", "50-100mg", "low dose", "epilepsy", "patients", "Benefits", "200-400mg", "two doses", "condition", "migraines", "Topiramate", "depression", "mood swings", "weight gain", "weight loss", "information", "Key Features", "sterispharma", "Introduction", "initial dose", "sterisonline", "CALL/WHATSAPP", "added benefit", "various types", "mood disorders", "patient safety", "Initial Dosage", "effective dose", "sodium channels", "dosage strength", "migraine attacks", "bipolar disorder", "weight reduction", "neuronal activity", "seizure frequency", "daily functioning", "other medications", "Weight Management", "Regular monitoring", "Mood Stabilization", "TP MATE 50 therapy", "glutamate activity", "TP MATE 50 tablets", "migraine prevention", "long-term management", "Migraine Prophylaxis", "Continued Monitoring", "common starting dose", "many anticonvulsants", "therapeutic efficacy", "Anticonvulsant Action", "usual maintenance dose", "potential side effects", "partial-onset seizures", "GABAergic transmission", "Lennox-Gastaut syndrome", "favorable safety profile", "versatile anticonvulsant", "neurotransmitter activity", "stable therapeutic levels", "Administration Instructions", "mood-stabilizing properties", "consistent dosing schedules", "migraine prophylactic medication", "generalized tonic-clonic seizures" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1905, "imageuri": "https://productimages.withfloats.com/actual/666c09bbf068be46bdec8995.png", "tileimageuri": "https://productimages.withfloats.com/tile/666c09bbf068be46bdec8995.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T09:13:28.046Z", "updatedon": "2024-06-26T06:01:34.175Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/tp-mate-50-/1905", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TP MATE 50 ", "category": "NEUROLOGY RANGE", "tags": [ "TP MATE 50", "", "Topiramate (50mg)", "topiramate uses", "topiramate 50 mg", "topiramate side effects", "topiramate side effects weight loss" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666c07d66641561b044696cc", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TARPEDO ER 50 ", "description": "TARPEDO ER 50 \nTapentadol HCL ER Tablets, (50mg)\nIntroduction:\n\nTARPEDO ER 50 contains Tapentadol HCL, an extended-release (ER) formulation designed for the management of moderate to severe chronic pain. With a dosage strength of 50mg, TARPEDO ER 50 provides sustained pain relief, improving the quality of life for patients who require long-term pain management.\nKey Features and Benefits:\n\nDual Mechanism of Action:\n\nOpioid Agonist: Tapentadol acts as a mu-opioid receptor agonist, providing potent analgesic effects by altering the perception of pain in the central nervous system.\nNorepinephrine Reuptake Inhibitor: It also inhibits the reuptake of norepinephrine, enhancing pain inhibition in the brain and spinal cord, contributing to its analgesic properties.\nExtended-Release Formulation:\n\nTARPEDO ER 50 is designed for extended release, ensuring a steady release of medication over a 12-hour period. This provides consistent pain control and reduces the need for frequent dosing.\nEffective Pain Management:\n\nSuitable for managing various types of chronic pain, including neuropathic pain, osteoarthritis, and lower back pain. TARPEDO ER 50 helps patients maintain daily activities and improve their overall quality of life.\nReduced Side Effects:\n\nCompared to other opioids, Tapentadol has a lower incidence of common opioid-related side effects such as nausea, vomiting, and constipation, making it a more tolerable option for long-term use.\nDosage and Administration:\n\nInitial Dosage:\n\nThe recommended starting dose of TARPEDO ER 50 is 50mg twice daily, approximately every 12 hours. Dosage should be adjusted based on individual patient response and tolerability.\nTitration and Maintenance:\n\nThe dose may be increased in increments of 50mg every 3 days as needed to achieve adequate pain control. The maximum recommended dose is 500mg per day.\nAdministration Instructions:\n\nSwallow TARPEDO ER 50 tablets whole with water. Do not crush, chew, or split the tablets to avoid rapid release of the drug, which can increase the risk of adverse effects.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/tarpedo-er-50-133971", "price": 148.0, "discountamount": 44.4, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "50mg", "life", "risk", "drug", "need", "Order", "EMAIL", "water", "500mg", "brain", "Action", "nausea", "option", "patients", "Benefits", "vomiting", "12 hours", "Titration", "medication", "perception", "increments", "information", "Maintenance", "spinal cord", "moderate to", "Introduction", "sterispharma", "sterisonline", "constipation", "tolerability", "Key Features", "CALL/WHATSAPP", "rapid release", "starting dose", "other opioids", "various types", "long-term use", "12-hour period", "osteoarthritis", "Initial Dosage", "Opioid Agonist", "steady release", "Dual Mechanism", "lower back pain", "pain inhibition", "lower incidence", "adverse effects", "overall quality", "dosage strength", "frequent dosing", "neuropathic pain", "daily activities", "extended release", "severe chronic pain", "analgesic properties", "Reduced Side Effects", "sustained pain relief", "adequate pain control", "central nervous system", "consistent pain control", "potent analgesic effects", "maximum recommended dose", "long-term pain management", "Tapentadol HCL ER Tablets", "Effective Pain Management", "mu-opioid receptor agonist", "individual patient response", "Administration Instructions", "Extended-Release Formulation", "Swallow TARPEDO ER 50 tablets", "Norepinephrine Reuptake Inhibitor", "extended-release (ER) formulation", "common opioid-related side effects" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1903, "imageuri": "https://productimages.withfloats.com/actual/666c07da0b4fc76a99a41803.png", "tileimageuri": "https://productimages.withfloats.com/tile/666c07da0b4fc76a99a41803.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T09:05:26.681Z", "updatedon": "2024-06-26T06:23:02.343Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/tarpedo-er-50-/1903", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TARPEDO ER 50 ", "category": "NEUROLOGY RANGE", "tags": [ "TARPEDO ER 50", "", "Tapentadol HCL ER Tablets, (50mg)", "", "tapentadol 50 mg side effects", "long-term side effects of tapentadol" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68b02393f5434d48fca8b8ca", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRELAQWK 50", "description": "TRELAQWK 50 is a modern oral antidiabetic tablet containing Trelagliptin 50 mg, specially developed for adults with type 2 diabetes mellitus. This once-weekly medication helps regulate blood sugar effectively, offering both convenience and strong clinical outcomes. With its advanced formulation, TRELAQWK 50 supports better glycemic control, making it easier for patients to lead a balanced and healthier lifestyle.\nManufactured under strict quality standards, TRELAQWK 50 ensures patient compliance, long-term safety, and efficacy in diabetes management.\nKey Ingredient\nTrelagliptin (50 mg):\nA unique, long-acting DPP-4 (dipeptidyl peptidase-4) inhibitor that allows weekly dosing, ensuring higher treatment adherence while maintaining effective control over blood glucose levels.\nKey Benefits of TRELAQWK 50\nProvides consistent blood sugar management with just one tablet per week\nEnhances insulin secretion while lowering glucagon levels in a glucose-dependent manner\nHelps reduce both fasting and postprandial blood glucose\nConvenient choice for patients with busy schedules who struggle with daily tablets\nLow risk of hypoglycemia when used as monotherapy\nSupports long-term improvement in HbA1c levels\nMechanism of Action – How TRELAQWK 50 Works\nTRELAQWK 50 works by blocking the DPP-4 enzyme, which normally degrades incretin hormones such as GLP-1 and GIP. These incretins are vital for maintaining blood sugar balance. By prolonging incretin activity, trelagliptin:\nStimulates insulin secretion from the pancreas\nReduces glucagon release from alpha cells\nHelps lower blood sugar, particularly after meals\nThis mechanism provides both effective glycemic control and improved patient compliance.\nDirections for Use\nTake one tablet of TRELAQWK 50 once a week, on the same day each week\nCan be taken with or without food\nSwallow whole with a glass of water\nFollow your doctor’s advice for dosage adjustment\nDo not double the dose if missed; consult your healthcare provider\nPossible Side Effects\nTRELAQWK 50 is usually well-tolerated. However, some patients may experience:\nMild headache\nNasopharyngitis (cold-like symptoms)\nDiarrhea\nStomach discomfort or indigestion\nRare allergic reactions (rash, itching)\nIf any unusual or persistent side effects occur, seek medical advice promptly.", "price": 375.0, "discountamount": 112.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2165, "imageuri": "https://productimages.withfloats.com/actual/68b023971624ba892ffd8c69.png", "tileimageuri": "https://productimages.withfloats.com/tile/68b023971624ba892ffd8c69.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-28T09:38:27.036Z", "updatedon": "2025-08-28T09:38:27.036Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trelaqwk-50/2165", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "trelagliptin 50 mg", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666c1007162db0236048bac5", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VALPOTREAT CR 500 ", "description": "VALPOTREAT CR 500 \nSodium Valproate CR 500 mg\nIntroduction:\n\nVALPOTREAT CR 500 contains Sodium Valproate, a potent anticonvulsant and mood stabilizer, in a controlled-release (CR) formulation. With a dosage strength of 500mg, VALPOTREAT CR 500 is designed to provide sustained therapeutic effects for managing epilepsy and bipolar disorder, significantly enhancing the quality of life for patients.\nKey Features and Benefits:\n\nAnticonvulsant Action:\n\nVALPOTREAT CR 500 is highly effective in treating various types of seizures, including generalized tonic-clonic seizures, absence seizures, and complex partial seizures. It increases gamma-aminobutyric acid (GABA) levels in the brain, helping stabilize neuronal activity and prevent seizure episodes.\nMood Stabilization:\n\nSodium Valproate is also used as a mood stabilizer for treating bipolar disorder. It helps control manic episodes and provides mood stability, reducing the frequency and severity of mood swings.\nControlled-Release Formulation:\n\nThe controlled-release formulation of VALPOTREAT CR 500 ensures a steady release of the medication over time, maintaining consistent blood levels and reducing the need for frequent dosing. This leads to better symptom control and improved adherence to the treatment regimen.\nWell-Tolerated and Safe:\n\nVALPOTREAT CR 500 is generally well-tolerated with a favorable safety profile, making it a reliable option for long-term management of epilepsy and bipolar disorder.\nDosage and Administration:\n\nInitial Dosage for Epilepsy:\n\nThe initial dose of VALPOTREAT CR 500 for adults typically starts at 500mg per day, divided into two doses. The dose can be gradually increased based on the patient's response and tolerability, with a usual maintenance dose ranging from 1000-2000mg per day.\nInitial Dosage for Bipolar Disorder:\n\nFor the treatment of bipolar disorder, the initial dose usually starts at 500mg per day, divided into two doses. The dose can be gradually increased based on clinical response, with a typical maintenance dose ranging from 1000-1500mg per day.\nAdministration Instructions:\n\nVALPOTREAT CR 500 tablets should be taken orally with water. They can be taken with or without food, although taking them with food may help reduce gastrointestinal discomfort.\nContinued Monitoring:\n\nRegular monitoring of blood levels, liver function, and overall health is essential during VALPOTREAT CR 500 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/valpotreat-cr-500-134217", "price": 121.18, "discountamount": 36.35, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mg", "day", "life", "food", "time", "need", "EMAIL", "water", "brain", "adults", "option", "product", "quality", "epilepsy", "severity", "patients", "Benefits", "frequency", "two doses", "adherence", "medication", "mood swings", "information", "initial dose", "GABA) levels", "tolerability", "sterispharma", "Key Features", "Introduction", "sterisonline", "various types", "CALL/WHATSAPP", "liver function", "Initial Dosage", "patient safety", "overall health", "manic episodes", "steady release", "mood stability", "mood stabilizer", "symptom control", "frequent dosing", "dosage strength", "seizure episodes", "absence seizures", "bipolar disorder", "treatment regimen", "clinical response", "neuronal activity", "Mood Stabilization", "Regular monitoring", "Sodium Valproate CR", "Continued Monitoring", "long-term management", "therapeutic efficacy", "Anticonvulsant Action", "potent anticonvulsant", "usual maintenance dose", "gamma-aminobutyric acid", "consistent blood levels", "favorable safety profile", "complex partial seizures", "typical maintenance dose", "VALPOTREAT CR 500 therapy", "VALPOTREAT CR 500 tablets", "gastrointestinal discomfort", "Administration Instructions", "sustained therapeutic effects", "Controlled-Release Formulation", "generalized tonic-clonic seizures", "controlled-release (CR) formulation" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1909, "imageuri": "https://productimages.withfloats.com/actual/666c100b8c6c791fd3b72fe4.png", "tileimageuri": "https://productimages.withfloats.com/tile/666c100b8c6c791fd3b72fe4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T09:40:23.921Z", "updatedon": "2024-06-26T05:53:21.154Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/valpotreat-cr-500-/1909", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VALPOTREAT CR 500 ", "category": "NEUROLOGY RANGE", "tags": [ "Sodium Valproate CR 500 mg", "VALPOTREAT CR 500", "", "VALPOTREAT CR 500 price", "", "valprol cr 500 uses and side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666c08e7c91739182c9574b6", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TP MATE 100 ", "description": "TP MATE 100 \nTopiramate (100mg)\nIntroduction:\n\nTP MATE 100 contains Topiramate, a broad-spectrum anticonvulsant and migraine prophylactic medication. With a dosage strength of 100mg, TP MATE 100 is designed to manage seizures in epilepsy and prevent migraines, significantly enhancing the quality of life for patients.\nKey Features and Benefits:\n\nAnticonvulsant Action:\n\nTP MATE 100 is highly effective in treating various types of seizures, including partial-onset seizures, generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome. It stabilizes neuronal activity by enhancing GABAergic transmission, blocking sodium channels, and inhibiting glutamate activity.\nMigraine Prophylaxis:\n\nTopiramate is widely used for preventing migraines. By modulating neurotransmitter activity, TP MATE 100 reduces the frequency and severity of migraine attacks, helping patients manage their condition and improve their daily functioning.\nWeight Management:\n\nAn added benefit of TP MATE 100 is its potential to assist with weight loss. Unlike many anticonvulsants, Topiramate may lead to weight reduction, which can be beneficial for patients concerned about weight gain associated with other medications.\nMood Stabilization:\n\nTopiramate has mood-stabilizing properties, making it useful for patients with coexisting mood disorders such as bipolar disorder. It helps in stabilizing mood swings and reducing symptoms of anxiety and depression.\nWell-Tolerated and Safe:\n\nTP MATE 100 is generally well-tolerated with a favorable safety profile, making it a reliable option for long-term management of epilepsy and migraines.\nDosage and Administration:\n\nInitial Dosage for Epilepsy:\n\nThe initial dose of TP MATE 100 for adults with epilepsy typically starts at a low dose, gradually increasing to reduce the risk of side effects. A common starting dose is 25-50mg per day, increasing weekly by 25-50mg until the effective dose is reached. The usual maintenance dose ranges from 200-400mg per day, divided into two doses.\nInitial Dosage for Migraine Prophylaxis:\n\nFor migraine prevention, the initial dose is 25mg taken once daily, usually at night. The dose may be increased weekly by 25mg, up to a recommended dose of 100mg per day, divided into two doses.\nAdministration Instructions:\n\nTP MATE 100 tablets should be taken orally with or without food. It is important to maintain consistent dosing schedules to ensure stable therapeutic levels.\nContinued Monitoring:\n\nRegular monitoring of seizure frequency, migraine attacks, and potential side effects is essential during TP MATE 100 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/tp-mate-100-133633", "price": 149.0, "discountamount": 44.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "life", "food", "25mg", "risk", "50mg", "EMAIL", "night", "100mg", "option", "adults", "anxiety", "quality", "symptoms", "severity", "low dose", "epilepsy", "patients", "Benefits", "200-400mg", "two doses", "condition", "migraines", "Topiramate", "depression", "mood swings", "weight gain", "weight loss", "information", "Key Features", "sterispharma", "Introduction", "initial dose", "sterisonline", "CALL/WHATSAPP", "added benefit", "various types", "mood disorders", "patient safety", "Initial Dosage", "effective dose", "sodium channels", "dosage strength", "migraine attacks", "bipolar disorder", "weight reduction", "neuronal activity", "seizure frequency", "daily functioning", "other medications", "Weight Management", "Regular monitoring", "Mood Stabilization", "glutamate activity", "migraine prevention", "TP MATE 100 therapy", "TP MATE 100 tablets", "long-term management", "Migraine Prophylaxis", "Continued Monitoring", "common starting dose", "many anticonvulsants", "therapeutic efficacy", "Anticonvulsant Action", "usual maintenance dose", "potential side effects", "partial-onset seizures", "GABAergic transmission", "Lennox-Gastaut syndrome", "favorable safety profile", "neurotransmitter activity", "stable therapeutic levels", "Administration Instructions", "mood-stabilizing properties", "consistent dosing schedules", "broad-spectrum anticonvulsant", "migraine prophylactic medication", "generalized tonic-clonic seizures" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1904, "imageuri": "https://productimages.withfloats.com/actual/666c08eb0b4fc76a99a41986.png", "tileimageuri": "https://productimages.withfloats.com/tile/666c08eb0b4fc76a99a41986.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T09:09:59.43Z", "updatedon": "2024-06-26T06:09:24.07Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/tp-mate-100-/1904", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TP MATE 100 ", "category": "NEUROLOGY RANGE", "tags": [ "tp mate 100 tablet price", "topiramate side effects weight loss", "topiramate side effects", "tp mate 100 tablet in hindi language" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666c06e12a9e3612903d86ea", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TARPEDO ER 100 ", "description": "TARPEDO ER 100 \nTapentadol HCL ER Tablets (100mg)\nIntroduction:\n\nTARPEDO ER 100 contains Tapentadol HCL, an extended-release (ER) formulation designed to manage moderate to severe chronic pain. With a dosage strength of 100mg, TARPEDO ER 100 offers sustained pain relief, improving the quality of life for patients who require long-term pain management.\nKey Features and Benefits:\n\nDual Mechanism of Action:\n\nOpioid Agonist: Tapentadol acts as a mu-opioid receptor agonist, providing potent analgesic effects by altering the perception of pain in the central nervous system.\nNorepinephrine Reuptake Inhibitor: It also inhibits the reuptake of norepinephrine, enhancing pain inhibition in the brain and spinal cord, which contributes to its analgesic properties.\nExtended-Release Formulation:\n\nTARPEDO ER 100 is designed for extended release, ensuring a steady release of medication over a 12-hour period. This provides consistent pain control and reduces the need for frequent dosing.\nEffective Pain Management:\n\nSuitable for managing various types of chronic pain, including neuropathic pain, osteoarthritis, and lower back pain. TARPEDO ER 100 helps patients maintain daily activities and improve their overall quality of life.\nReduced Side Effects:\n\nCompared to other opioids, Tapentadol has a lower incidence of common opioid-related side effects such as nausea, vomiting, and constipation, making it a more tolerable option for long-term use.\nDosage and Administration:\n\nInitial Dosage:\n\nThe recommended starting dose of TARPEDO ER 100 is 100mg twice daily, approximately every 12 hours. Dosage should be adjusted based on individual patient response and tolerability.\nTitration and Maintenance:\n\nThe dose may be increased in increments of 50mg to 100mg every 3 days as needed to achieve adequate pain control. The maximum recommended dose is 500mg per day.\nAdministration Instructions:\n\nSwallow TARPEDO ER 100 tablets whole with water. Do not crush, chew, or split the tablets to avoid rapid release of the drug, which can increase the risk of adverse effects.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/tarpedo-er-100-133972", "price": 278.0, "discountamount": 83.4, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "need", "50mg", "drug", "risk", "life", "EMAIL", "water", "Order", "500mg", "100mg", "brain", "nausea", "Action", "option", "Benefits", "vomiting", "patients", "12 hours", "Titration", "medication", "increments", "perception", "spinal cord", "Maintenance", "information", "moderate to", "Introduction", "sterisonline", "constipation", "tolerability", "sterispharma", "Key Features", "CALL/WHATSAPP", "rapid release", "other opioids", "starting dose", "various types", "long-term use", "Opioid Agonist", "Dual Mechanism", "steady release", "12-hour period", "osteoarthritis", "Initial Dosage", "overall quality", "dosage strength", "lower incidence", "frequent dosing", "pain inhibition", "adverse effects", "lower back pain", "extended release", "neuropathic pain", "daily activities", "severe chronic pain", "analgesic properties", "Reduced Side Effects", "sustained pain relief", "adequate pain control", "central nervous system", "consistent pain control", "potent analgesic effects", "maximum recommended dose", "Effective Pain Management", "long-term pain management", "Tapentadol HCL ER Tablets", "mu-opioid receptor agonist", "Administration Instructions", "individual patient response", "Extended-Release Formulation", "Swallow TARPEDO ER 100 tablets", "Norepinephrine Reuptake Inhibitor", "extended-release (ER) formulation", "common opioid-related side effects" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1902, "imageuri": "https://productimages.withfloats.com/actual/666c06e4117f82c50b0d0236.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666c06e4117f82c50b0d0236.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T09:01:21.805Z", "updatedon": "2024-06-26T06:25:00.472Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/tarpedo-er-100-/1902", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TARPEDO ER 100 ", "category": "NEUROLOGY RANGE", "tags": [ "long-term side effects of tapentadol", "tapentadol er 100 mg", "TARPEDO ER100", "tapentadol 50 mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666c03124cb45413344ec7be", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SUMATROPH 50 ", "description": "SUMATROPH 50 \nSumatriptan succinate Rapid- Release (50mg)\nIntroduction:\n\nSUMATROPH 50 contains Sumatriptan succinate, a selective serotonin receptor agonist (triptan) used for the acute treatment of migraine attacks. With a dosage strength of 50mg in a rapid-release formulation, SUMATROPH 50 offers quick and effective relief from the debilitating symptoms of migraines, helping patients regain control over their daily lives.\nKey Features and Benefits:\n\nRapid-Release Formulation:\n\nSUMATROPH 50 is designed to provide rapid relief from migraine symptoms. Its quick absorption and onset of action help alleviate headache pain, nausea, and sensitivity to light and sound within a short period.\nTargeted Action:\n\nSumatriptan succinate specifically targets serotonin (5-HT1) receptors in the brain, leading to the constriction of dilated blood vessels, which is believed to be a primary cause of migraine pain. This targeted action effectively reduces the intensity and duration of migraine attacks.\nSymptom Relief:\n\nSUMATROPH 50 not only alleviates headache pain but also helps relieve associated migraine symptoms such as nausea, vomiting, and photophobia (sensitivity to light) or phonophobia (sensitivity to sound), providing comprehensive symptom relief.\nImproved Quality of Life:\n\nBy providing quick and effective relief from migraines, SUMATROPH 50 enables patients to resume their daily activities with minimal disruption, enhancing their overall quality of life.\nWell-Tolerated and Safe:\n\nSumatriptan is generally well-tolerated, with a favorable safety profile, making SUMATROPH 50 a reliable option for the acute treatment of migraines.\nDosage and Administration:\n\nInitial Dosage:\n\nThe recommended dose of SUMATROPH 50 for adults is 50mg taken orally at the first sign of a migraine attack. The dose may be increased to 100mg if needed, based on individual response and tolerability.\nMaximum Dosage:\n\nDo not exceed 200mg in a 24-hour period. If the migraine returns after initial relief, a second dose may be taken at least 2 hours after the first dose.\nAdministration Instructions:\n\nSwallow SUMATROPH 50 tablets whole with water. The rapid-release formulation ensures quick absorption and onset of action.\nContinued Monitoring:\n\nRegular monitoring of migraine frequency, severity, and response to treatment is essential to optimize therapy and ensure patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/sumatroph-50-133683", "price": 148.4, "discountamount": 44.52, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Life", "50mg", "light", "100mg", "onset", "sound", "brain", "200mg", "Order", "water", "EMAIL", "adults", "nausea", "option", "therapy", "control", "duration", "severity", "patients", "vomiting", "Benefits", "intensity", "migraines", "first sign", "first dose", "sensitivity", "second dose", "photophobia", "daily lives", "phonophobia", "information", "constriction", "Introduction", "sterisonline", "tolerability", "Key Features", "short period", "rapid relief", "sterispharma", "primary cause", "headache pain", "CALL/WHATSAPP", "migraine pain", "patient safety", "24-hour period", "Initial Dosage", "Maximum Dosage", "initial relief", "acute treatment", "dosage strength", "Targeted Action", "overall quality", "effective relief", "quick absorption", "Improved Quality", "daily activities", "migraine attacks", "minimal disruption", "Regular monitoring", "migraine frequency", "individual response", "Continued Monitoring", "debilitating symptoms", "dilated blood vessels", "favorable safety profile", "rapid-release formulation", "serotonin (5-HT1) receptors", "Administration Instructions", "Swallow SUMATROPH 50 tablets", "associated migraine symptoms", "comprehensive symptom relief", "Sumatriptan succinate Rapid- Release", "selective serotonin receptor agonist" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1900, "imageuri": "https://productimages.withfloats.com/actual/666c03182d43284d72746dc6.png", "tileimageuri": "https://productimages.withfloats.com/tile/666c03182d43284d72746dc6.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T08:45:06.277Z", "updatedon": "2024-06-29T12:24:49.64Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sumatroph-50-/1900", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SUMATROPH 50 ", "category": "NEUROLOGY RANGE", "tags": [ "SUMATROPH 50", "", "sumatriptan 50 mg tablet uses", "Sumatriptan succinate Rapid- Release (50mg)", "sumatriptan side effects", "sumatriptan 50 mg tablet price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666bf380aa93342004eef764", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SERTINEC 50 ", "description": "SERTINEC 50 \nSertraline (50mg)\nIntroduction:\n\nSERTINEC 50 contains Sertraline, a selective serotonin reuptake inhibitor (SSRI) that is widely used to treat depression, anxiety disorders, and related conditions. With a dosage strength of 50mg, SERTINEC 50 aims to alleviate symptoms by enhancing serotonin levels in the brain, thereby improving mood and overall emotional well-being.\nKey Features and Benefits:\n\nAntidepressant Efficacy:\n\nSERTINEC 50 works by inhibiting the reuptake of serotonin, a neurotransmitter that regulates mood, emotion, and sleep. This action increases serotonin levels in the brain, helping to alleviate symptoms of major depressive disorder such as persistent sadness, lack of interest in activities, and fatigue.\nAnxiety Disorder Management:\n\nSERTINEC 50 is effective in treating various anxiety disorders, including generalized anxiety disorder (GAD), panic disorder, social anxiety disorder, and post-traumatic stress disorder (PTSD). It helps reduce excessive worry, panic attacks, and social fears, promoting a calmer and more stable emotional state.\nObsessive-Compulsive Disorder (OCD) Treatment:\n\nSERTINEC 50 is used to manage OCD, which is characterized by unwanted, persistent thoughts and repetitive behaviors. By modulating serotonin levels, Sertraline helps decrease the frequency and intensity of obsessive thoughts and compulsive actions.\nPremenstrual Dysphoric Disorder (PMDD) Relief:\n\nFor women suffering from PMDD, SERTINEC 50 can provide significant relief from severe emotional and physical symptoms that occur before menstruation, such as mood swings, irritability, and bloating.\nWell-Tolerated and Safe:\n\nSertraline is generally well-tolerated with a favorable safety profile, making SERTINEC 50 a reliable option for long-term management of depression and anxiety disorders.\nDosage and Administration:\n\nInitial Dosage:\n\nThe recommended starting dose of SERTINEC 50 is 50mg once daily. This dose may be adjusted based on the patient's response and tolerance, with the healthcare provider determining the appropriate dosage.\nAdministration Instructions:\n\nSERTINEC 50 tablets should be taken orally with or without food. It is advisable to take the medication at the same time each day to maintain consistent therapeutic levels in the bloodstream.\nTreatment Duration:\n\nContinue taking SERTINEC 50 as prescribed, even if symptoms improve, to prevent relapse. Abrupt discontinuation should be avoided to prevent withdrawal symptoms; any changes in dosage should be supervised by a healthcare provider.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/sertinec-50-133630", "price": 54.7, "discountamount": 16.41, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "GAD", "food", "lack", "PTSD", "SSRI", "50mg", "EMAIL", "brain", "women", "sleep", "calmer", "changes", "fatigue", "patient", "relapse", "Benefits", "interest", "response", "bloating", "frequency", "intensity", "same time", "tolerance", "activities", "medication", "depression", "Sertraline", "bloodstream", "information", "mood swings", "menstruation", "irritability", "Introduction", "PMDD) Relief", "sterisonline", "sterispharma", "social fears", "Key Features", "starting dose", "CALL/WHATSAPP", "panic attacks", "Initial Dosage", "OCD) Treatment", "panic disorder", "reliable option", "dosage strength", "severe emotional", "serotonin levels", "neurotransmitter", "physical symptoms", "compulsive actions", "Treatment Duration", "obsessive thoughts", "persistent sadness", "significant relief", "related conditions", "appropriate dosage", "SERTINEC 50 tablets", "healthcare provider", "withdrawal symptoms", "long-term management", "repetitive behaviors", "stable emotional state", "Abrupt discontinuation", "Antidepressant Efficacy", "social anxiety disorder", "favorable safety profile", "various anxiety disorders", "major depressive disorder", "Administration Instructions", "Anxiety Disorder Management", "generalized anxiety disorder", "overall emotional well-being", "unwanted, persistent thoughts", "consistent therapeutic levels", "Obsessive-Compulsive Disorder", "post-traumatic stress disorder", "Premenstrual Dysphoric Disorder", "selective serotonin reuptake inhibitor" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1897, "imageuri": "https://productimages.withfloats.com/actual/667d158ece74849f89cdd653.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d158ece74849f89cdd653.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T07:38:40.674Z", "updatedon": "2024-06-29T12:28:58.886Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sertinec-50-/1897", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SERTINEC 50 ", "category": "NEUROLOGY RANGE", "tags": [ "sertraline 50mg side effects", "SERTINEC 50", "", "sertraline side effects first week", "sertraline side effects first week", "sertraline 50 mg uses in hindi" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666ae3f4b453b6167c50636f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "QT-PINE 50 ", "description": "QT-PINE 50 \nQuetiapine (50mg)\nIntroduction:\n\nQT-PINE 50 encapsulates the therapeutic prowess of Quetiapine, an esteemed atypical antipsychotic renowned for its efficacy in managing a spectrum of psychiatric conditions. With a dosage strength of 50mg, QT-PINE 50 aims to harmonize mental health by addressing specific symptoms and promoting stability.\nKey Features and Benefits:\n\nAntipsychotic Efficacy:\n\nQuetiapine, the cornerstone of QT-PINE 50, exerts its antipsychotic effects by modulating dopamine and serotonin receptors, alleviating symptoms like hallucinations, delusions, and cognitive distortions in conditions such as schizophrenia.\nMood Stabilization:\n\nQT-PINE 50 aids in stabilizing mood fluctuations associated with bipolar disorder, helping to mitigate manic and depressive episodes and fostering emotional equilibrium.\nDepression Management:\n\nBeyond its antipsychotic properties, Quetiapine in QT-PINE 50 exhibits antidepressant effects by enhancing serotonin and norepinephrine activity, making it beneficial for individuals grappling with major depressive disorder (MDD).\nAnxiolytic Support:\n\nQT-PINE 50's anxiolytic attributes contribute to reducing anxiety symptoms prevalent in generalized anxiety disorder (GAD) and social anxiety disorder (SAD), promoting a sense of calmness and composure.\nDosage and Administration:\n\nInitiation and Adjustment:\nThe recommended starting dose of QT-PINE 50 is 50mg administered orally once daily. Dosage adjustments should be made judiciously under medical supervision based on individual response and tolerability.\nAdministration Guidance:\nQT-PINE 50 tablets should be swallowed whole with water, not crushed or chewed, and taken consistently at the same time daily for optimal therapeutic outcomes.\nTreatment Duration:\nContinuation of QT-PINE 50 should align with healthcare provider recommendations, even if symptom improvement is noted, to sustain therapeutic benefits and prevent relapse.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/qt-pine-50-133618", "price": 55.0, "discountamount": 16.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "SAD", "GAD", "MDD", "50mg", "EMAIL", "manic", "sense", "water", "product", "relapse", "dopamine", "spectrum", "calmness", "delusions", "composure", "stability", "same time", "Initiation", "Quetiapine", "individuals", "cornerstone", "information", "Introduction", "sterisonline", "sterispharma", "Continuation", "tolerability", "Key Features", "schizophrenia", "mental health", "starting dose", "CALL/WHATSAPP", "hallucinations", "dosage strength", "QT-PINE 50 aids", "bipolar disorder", "anxiety symptoms", "specific symptoms", "mood fluctuations", "Treatment Duration", "Dosage adjustments", "Anxiolytic Support", "Mood Stabilization", "QT-PINE 50 tablets", "serotonin receptors", "therapeutic prowess", "depressive episodes", "symptom improvement", "individual response", "medical supervision", "therapeutic benefits", "antipsychotic effects", "anxiolytic attributes", "Depression Management", "emotional equilibrium", "cognitive distortions", "psychiatric conditions", "Antipsychotic Efficacy", "antidepressant effects", "atypical antipsychotic", "norepinephrine activity", "social anxiety disorder", "Administration Guidance", "antipsychotic properties", "major depressive disorder", "optimal therapeutic outcomes", "generalized anxiety disorder", "healthcare provider recommendations" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1886, "imageuri": "https://productimages.withfloats.com/actual/667d1603c134db5b38ba48f4.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d1603c134db5b38ba48f4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T12:20:04.778Z", "updatedon": "2024-06-27T07:34:25.408Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/qt-pine-50-/1886", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "QT-PINE 50 ", "category": "NEUROLOGY RANGE", "tags": [ "quetiapine 50 mg uses", "quetiapine side effects", "QT-PINE 50", "", "quetiapine for sleep", "quetiapine for sleep side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }